What are Recombinant quadrivalent HPV vaccine drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recombinant quadrivalent HPV vaccine drugs are pharmacologic agents that share a common mechanism (typically targeting Human papillomavirus (HPV) types 6, 11, 16, 18). 0 are currently marketed, with 3 more in clinical development.

Recombinant quadrivalent HPV vaccine

0 marketed 3 in Phase 3

This page covers all Recombinant quadrivalent HPV vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Human papillomavirus (HPV) types 6, 11, 16, 18, Human papillomavirus (HPV) types 6, 11, 16, 18 L1 capsid protein.

Targets

Human papillomavirus (HPV) types 6, 11, 16, 18 · Human papillomavirus (HPV) types 6, 11, 16, 18 L1 capsid protein

Phase 3 pipeline (3)

Vaccination with Gardasil · Assistance Publique - Hôpitaux de Paris · Oncology / Immunology / Infectious Disease
Gardasil is a recombinant quadrivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 6, 11, 16, and 18.
Comparator: Gardasil · Merck Sharp & Dohme LLC · Oncology / Immunology / Infectious Disease
Gardasil is a recombinant quadrivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 6, 11, 16, and 18.
Gardasil as three dose regimen · Serum Institute of India Pvt. Ltd. · Oncology / Infectious Disease / Immunology
Gardasil is a recombinant quadrivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 6, 11, 16, and 18.

Patent intelligence

recombinant quadrivalent hpv vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates